Newsinvest
VC Fund
Paris, France
Newsinvest is a VC fund in Paris focused on Software and Health Care. News Invest SA is a France-based company that provides on-line and off-line marketing and information services. It operates through two divisions, including Digital, specialized in media and marketing strategies, on-line and mobile communication and interactive advertising, among others, and Corporate, providing consulting services in the area ofcorporate, financial and environmental communication, among others. In addition, the Company operates a Website, www.newsinvest.fr, where it distributes financial and investment information.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Newsinvest invests in
Stages Newsinvest invests in
Countries Newsinvest invests in
Round sizes
Round size
- Seed
- $1.1M–$2.2M
- Series A
- $2.3M–$2.7M
- Venture - Series Unknown
- $1.1M–$10M
Investment Focus
Industry
- Software 2 (33%)
- Health Care 2 (33%)
- TV 1 (17%)
- News 1 (17%)
- Events 1 (17%)
Stage
- Seed 2 (33%)
- Series A 2 (33%)
- Venture - Series Unknown 2 (33%)
Country
- France 4 (67%)
- Belgium 2 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bird Office has been created in December 2013 by Arnaud Katz, Michael Zribi and Kevin Dréno. Bird Office is an all inclusive service, enabling companies to organise their meetings, trainings, seminars and conferences with ease. Choose from carefully selected venues, for any professional events with a capacity of 2 to 400 attendees. Hire for anhour, a day or even several weeks.Within 10 minutes, a company is able to find their ideal venue along with any extra services required (mostly catering) in order to organise a successful event. | $10.3M / Venture - Series Unknown / Jul 05, 2022 | ||
| Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis. | $2.2M / Seed / Apr 27, 2017 | ||
| For the past 5 years, Realytics has been measuring the performance of digital TV campaigns (website, mobile app, call center ...). With this data collected and analyzed, Realytics is today the first player to digitize the TV buying process by allowing the automatic construction of TV media plans.With more than 2,5 millions TV spots analysed and+5 years of R&D behind them, Realytics now provides its clients with the ability to gain ever-increasing value from TV, thanks to a few major innovations: Ad Performance: Realytics allows advertisers to measure, in real-time, the impact of TV campaigns on digital (website, mobile app ...) thanks to a proprietary spot detection technology from the first second of broadcast. Ad Perf 360: In early 2019, Realytics announced the release of Ad Perf 360, a new solution measuring the performance of delinear TV advertising campaigns, allowing, for the first time, to reconcile linear and delinear data performances. Ad Sync: With this solution, advertisers can boost the digital performance of their campaigns by synchronizing their Adwords campaigns with their TV ads in real time. Digital Follow-up: Thanks to a very advanced scoring technology, Realytics is able to identify visitors who have been exposed to a TV campaign and to re-expose this captive audience during their web browsing. Brand Effect: Realytics allows advertisers to know the effect of their TV campaign, analyzing its effect on the search, also discovering the audience they've reach in TV. Predict Impact: Thanks to the power of Realytics algorithms, it is possible to estimate the effectiveness of a media plan and to predict its performance. Ad Plan: As the first artificial intelligence that introduces TV media buying based on a guaranteed cost per TV visit, Ad Plan delivers advertisers the optimal media plan according to their budget, their media constraints and their performance objectives in visits. | $2.7M / Series A / Mar 29, 2017 | ||
| ZIQY is the ultimate subscription management platform : ziqy.co | $1.1M / Seed / Jan 13, 2017 | ||
| Pharmsimple est une parapharmacie en ligne située en Belgique. L’importance de Pharmasimple permet de négocier avec les différents laboratoires partenaires des remises importantes ce qui permet à Pharmasimple de vous proposer des prix très bas. | $1.1M / Venture - Series Unknown / Oct 03, 2016 | ||
| Newsmonkey is a news website that is driven by social media and the virality of news. It shares content targeting t18- to 34-year-old digital readers.The site is funded by advertising. Its native advertising strategy makes neutral content for brands that is shared throughout social media.Newsmonkey was launched in January 2013 and is operatedfrom Brussels, Belgium. | $2.3M / Series A / May 07, 2015 |
Co-Investors
BNP Paribas Développement
2 deals together
Bpifrance
2 deals together
Elaia
2 deals together
AzurInvest
1 deal together
CapHorn Invest
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Newsinvest invest in?
Newsinvest invests primarily in Software, Health Care and TV startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Newsinvest's check size?
Newsinvest typically joins rounds of $1.1M–$2.2M at Seed, $2.3M–$2.7M at Series A and $1.1M–$10M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Newsinvest participates in.
When did Newsinvest last invest?
The most recent investment recorded for Newsinvest closed in Jul 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
